MK-0677 (ibutamoren mesylate) for the treatment of patients recovering from hip fracture: A multicenter, randomized, placebo-controlled phase IIb study

✍ Scribed by Abraham Adunsky; Julie Chandler; Norman Heyden; Jeannine Lutkiewicz; Boyd B. Scott; Yuliya Berd; Nancy Liu; Dimitris A. Papanicolaou

• Publisher: Elsevier Science
• Year: 2011
• Tongue: English
• Weight: 305 KB
• Volume: 53
• Category: Article
• ISSN: 0167-4943
• DOI: 10.1016/j.archger.2010.10.004